Lymphedema self-care: economic cost savings and opportunities to improve adherence.
Breast cancer-related lymphedema
Cancer survivors
Complications
Economic benefit
Economic burden
Pneumatic compression device
Quality of life
Self-care
Journal
Cost effectiveness and resource allocation : C/E
ISSN: 1478-7547
Titre abrégé: Cost Eff Resour Alloc
Pays: England
ID NLM: 101170476
Informations de publication
Date de publication:
29 Jul 2023
29 Jul 2023
Historique:
received:
13
01
2023
accepted:
20
07
2023
medline:
30
7
2023
pubmed:
30
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Breast cancer-related lymphedema (BCRL) imposes a significant economic burden on patients, providers, and society. There is no curative therapy for BCRL, but management through self-care can reduce symptoms and lower the risk of adverse events. The economic burden of BCRL stems from related adverse events, reductions in productivity and employment, and the burden placed on non-medical caregivers. Self-care regimens often include manual lymphatic drainage, compression garments, and meticulous skin care, and may incorporate pneumatic compression devices. These regimens can be effective in managing BCRL, but patients cite inconvenience and interference with daily activities as potential barriers to self-care adherence. As a result, adherence is generally poor and often worsens with time. Because self-care is on-going, poor adherence reduces the effectiveness of regimens and leads to costly treatment of BCRL complications. Novel self-care solutions that are more convenient and that interfere less with daily activities could increase self-care adherence and ultimately reduce complication-related costs of BCRL.
Sections du résumé
BACKGROUND
BACKGROUND
Breast cancer-related lymphedema (BCRL) imposes a significant economic burden on patients, providers, and society. There is no curative therapy for BCRL, but management through self-care can reduce symptoms and lower the risk of adverse events.
MAIN BODY
METHODS
The economic burden of BCRL stems from related adverse events, reductions in productivity and employment, and the burden placed on non-medical caregivers. Self-care regimens often include manual lymphatic drainage, compression garments, and meticulous skin care, and may incorporate pneumatic compression devices. These regimens can be effective in managing BCRL, but patients cite inconvenience and interference with daily activities as potential barriers to self-care adherence. As a result, adherence is generally poor and often worsens with time. Because self-care is on-going, poor adherence reduces the effectiveness of regimens and leads to costly treatment of BCRL complications.
CONCLUSION
CONCLUSIONS
Novel self-care solutions that are more convenient and that interfere less with daily activities could increase self-care adherence and ultimately reduce complication-related costs of BCRL.
Identifiants
pubmed: 37516870
doi: 10.1186/s12962-023-00455-7
pii: 10.1186/s12962-023-00455-7
pmc: PMC10386258
doi:
Types de publication
Letter
Langues
eng
Pagination
47Informations de copyright
© 2023. The Author(s).
Références
Springerplus. 2016 May 17;5:657
pubmed: 27330922
Support Care Cancer. 2021 Jul;29(7):3801-3813
pubmed: 33236211
JAMA Dermatol. 2015 Nov;151(11):1187-93
pubmed: 26444458
J Pers Med. 2015 Nov 16;5(4):370-88
pubmed: 26580657
J Clin Oncol. 2009 Apr 20;27(12):2007-14
pubmed: 19289624
J Clin Oncol. 2009 Jan 20;27(3):390-7
pubmed: 19064976
CMAJ. 2001 Jan 23;164(2):191-9
pubmed: 11332311
J Clin Nurs. 2023 Mar;32(5-6):926-940
pubmed: 36101935
Eur J Breast Health. 2019 Feb 15;15(2):111-118
pubmed: 31001613
Am J Surg. 2016 Jan;211(1):133-41
pubmed: 26421413
Support Care Cancer. 2021 Dec;29(12):8027-8044
pubmed: 34226959
Support Care Cancer. 2011 Jul;19(7):935-40
pubmed: 20495983
Appl Nurs Res. 2020 Aug;54:151301
pubmed: 32650885
PLoS One. 2014 Dec 03;9(12):e114597
pubmed: 25470383
Support Care Cancer. 2014 Jan;22(1):135-43
pubmed: 24013569
Lymphology. 2014 Sep;47(3):142-50
pubmed: 25420307
Am J Phys Med Rehabil. 2015 Apr;94(4):288-96
pubmed: 25171662
Support Care Cancer. 2020 Feb;28(2):439-449
pubmed: 31656987
Ann Vasc Surg. 2020 Feb;63:298-306
pubmed: 31629128
Lymphat Res Biol. 2022 Dec;20(6):665-670
pubmed: 35245100
Support Care Cancer. 2016 Jan;24(1):139-146
pubmed: 25957012
J Vasc Surg Venous Lymphat Disord. 2022 Nov;10(6):1359-1366.e1
pubmed: 35952956